NO853700L - Blodkoaguleringshemmende proteiner og fremgangsm¨te for fr emstilling derav. - Google Patents

Blodkoaguleringshemmende proteiner og fremgangsm¨te for fr emstilling derav.

Info

Publication number
NO853700L
NO853700L NO853700A NO853700A NO853700L NO 853700 L NO853700 L NO 853700L NO 853700 A NO853700 A NO 853700A NO 853700 A NO853700 A NO 853700A NO 853700 L NO853700 L NO 853700L
Authority
NO
Norway
Prior art keywords
preparing
procedure
inhibiting proteins
coagulator
blood
Prior art date
Application number
NO853700A
Other languages
English (en)
Other versions
NO164991B (no
NO164991C (no
Inventor
Christian Pet Reutelingsperger
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26645980&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO853700(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from NL8402904A external-priority patent/NL8402904A/nl
Priority claimed from NL8500601A external-priority patent/NL8500601A/nl
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of NO853700L publication Critical patent/NO853700L/no
Publication of NO164991B publication Critical patent/NO164991B/no
Publication of NO164991C publication Critical patent/NO164991C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Analytical Chemistry (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO853700A 1984-09-21 1985-09-20 Fremgangsmaate for fremstilling av blodkoaguleringshemmende proteiner. NO164991C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL8402904A NL8402904A (nl) 1984-09-21 1984-09-21 De bloedstolling remmend eiwitmateriaal, werkwijze voor het isoleren daarvan alsmede farmaceutisch preparaat.
NL8500601A NL8500601A (nl) 1985-03-04 1985-03-04 Uit biologisch materiaal isoleerbaar, de bloedstolling remmend eiwitmateriaal, werkwijzen voor het isoleren en zuiveren daarvan alsmede farmaceutisch preparaat.

Publications (3)

Publication Number Publication Date
NO853700L true NO853700L (no) 1986-03-24
NO164991B NO164991B (no) 1990-08-27
NO164991C NO164991C (no) 1990-12-05

Family

ID=26645980

Family Applications (1)

Application Number Title Priority Date Filing Date
NO853700A NO164991C (no) 1984-09-21 1985-09-20 Fremgangsmaate for fremstilling av blodkoaguleringshemmende proteiner.

Country Status (17)

Country Link
US (2) US4736018A (no)
EP (1) EP0181465B2 (no)
JP (1) JPH0780912B2 (no)
KR (1) KR930007434B1 (no)
AU (1) AU596951B2 (no)
CA (1) CA1244763A (no)
DE (2) DE3572179D1 (no)
DK (1) DK166587B1 (no)
ES (1) ES8702431A1 (no)
FI (1) FI83882C (no)
HU (1) HU199883B (no)
IE (1) IE58862B1 (no)
IL (1) IL76441A (no)
NO (1) NO164991C (no)
NZ (1) NZ213563A (no)
PH (1) PH23942A (no)
PT (1) PT81168B (no)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3750664T2 (de) * 1986-07-15 1995-06-22 Kowa Co Throminbindende Substanz und Verfahren zu ihrer Herstellung.
US4962022A (en) * 1986-09-22 1990-10-09 Becton Dickinson And Company Storage and use of liposomes
JPH08840B2 (ja) * 1986-11-14 1996-01-10 興和株式会社 抗ｐｃｉモノクローナル抗体、これを用いた抗ｐｃｉの精製法及び免疫学的測定法
US4937324A (en) * 1987-02-06 1990-06-26 Zymogenetics, Inc. Chromatographic purification of human proteins having anticoagulant and anti-inflammatory activity
DE3710364A1 (de) * 1987-03-28 1989-01-19 Boehringer Ingelheim Int Vascular-antikoagulierende proteine, dna die diese kodieren, verfahren zu deren herstellung sowie deren verwendung
PT87083B (pt) * 1987-03-28 1992-07-31 Boehringer Ingelheim Int Processo para a preparacao de uma proteina anticoagulante vascular, de adn que codifica para esta proteina e de composicoes farmaceuticas que a contem
DE3710430A1 (de) * 1987-03-28 1989-01-19 Boehringer Ingelheim Int Vascular-antikoagulierende proteine, dna die diese kodieren, verfahren zu deren herstellung sowie deren verwendung
DE3737367A1 (de) * 1987-11-04 1989-05-24 Boehringer Ingelheim Int Vascular-antikoagulierende proteine, dna die diese kodieren, verfahren zu deren herstellung sowie deren verwendung
DE3724726A1 (de) * 1987-07-25 1989-02-02 Behringwerke Ag Verfahren zur reinigung des plazentaren gewebeproteins pp4
US5187155A (en) * 1989-06-23 1993-02-16 Board Of Regents, The University Of Texas System Anticoagulant peptides
ES2045669T3 (es) * 1989-07-15 1994-01-16 Boehringer Ingelheim Int Procedimiento para la purificacion de anexinas.
ATE89169T1 (de) * 1989-07-15 1993-05-15 Boehringer Ingelheim Int Antikoagulanz enthaltendes mittel.
US5190919A (en) * 1989-11-13 1993-03-02 Board Of Regents, The University Of Texas System Antihemostatic factor vii peptides
US5627036A (en) * 1989-12-27 1997-05-06 Boehringer Ingelheim International Gmbh Use of an anticoagulant as a diagnostic agent
IE73210B1 (en) * 1990-01-24 1997-05-07 Warner Lambert Co Process for the production of thrombin and high purity thrombin preparation thereby obtained
AU2870992A (en) * 1991-10-04 1993-05-03 Board Of Regents Of The University Of Nebraska, The A soluble thrombomodulin-based one-stage assay for vitamin k-dependent coagulation-inhibiting proteins
US5716795A (en) * 1991-10-04 1998-02-10 Matschiner; John T. Thrombomodulin-based coagulometric assay of the protein C system
US5266462A (en) * 1992-06-03 1993-11-30 Baxter Diagnostics Inc. Measurement of platelet activities
JPH078298A (ja) * 1993-06-28 1995-01-13 Nippon Shoji Kk アンチトロンビンｉｉｉ活性の測定方法および該測定用試薬キット
US5455338A (en) * 1993-11-05 1995-10-03 Zymogenetics, Inc. DNA encoding novel human kunitz-type inhibitors and methods relating thereto
US5968477A (en) 1994-01-24 1999-10-19 Neorx Corporation Radiolabeled annexin conjugates with hexose and a chelator
US20030220233A1 (en) 1994-01-24 2003-11-27 Neorx Corporation Radiolabeled annexins
US5985582A (en) * 1997-12-09 1999-11-16 Sigma-Aldrich Co. Thrombin-based assay for antithrombin III
WO2000077246A2 (en) 1999-06-14 2000-12-21 Novo Nordisk A/S A METHOD FOR IDENTIFYING A DRUG CANDIDATE HAVING AN INHIBITORY ACTION ON FVII-TF ACTIVITY, AND FVIIa/TF ACTIVITY INHIBITING COMPOUNDS
EP1839670A3 (en) * 2001-02-21 2009-11-11 Alavita Pharmaceuticals, Inc. Modified Annexin Proteins and their use against thrombosis
US20090291086A1 (en) * 2001-02-21 2009-11-26 Alavita Pharmaceuticals, Inc. Compositions and Methods for Treating Cerebral Thrombosis and Global Cerebral Ischemia
US7635680B2 (en) * 2001-02-21 2009-12-22 Alavita Pharmaceuticals, Inc. Attenuation of reperfusion injury
US7635676B2 (en) * 2001-02-21 2009-12-22 Alavita Pharmaccuticals, Inc. Modified annexin proteins and methods for their use in organ transplantation
US7645739B2 (en) * 2001-02-21 2010-01-12 Alavita Pharmaceuticals, Inc. Modified annexin compositions and methods of using same
BR0208203A (pt) 2001-03-22 2005-04-19 Novo Nordisk Healthcare Ag Polipeptìdeo do fator vii, derivado do fator vii, composição, composição farmacêutica, construção de polinucleotìdeo, célula hospedeira eucariótica, animal transgênico, planta transgênica, e, métodos para produzir o polipeptìdeo do fator vii e um derivado do fator vii, uso de um derivado do fator vii, métodos para o tratamento de episódios de hemorragia ou distúrbios de hemorragia em um paciente ou para a intensificação do sistema hemostático normal e para inibir a formação de trobo em um paciente
US8364342B2 (en) * 2001-07-31 2013-01-29 Immersion Corporation Control wheel with haptic feedback
US6982154B2 (en) 2002-02-21 2006-01-03 Surromed, Inc. Modified annexin proteins and methods for treating vaso-occlusive sickle-cell disease
US7029468B2 (en) * 2002-06-25 2006-04-18 Enpath Medical, Inc. Catheter assembly with side wall exit lumen and method therefor
US20080269857A1 (en) * 2007-04-30 2008-10-30 Cross Thomas E Implantable medical leads and lead assemblies with flexibility, extensibility and branched structures

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL43343A (en) * 1972-10-24 1976-03-31 Lilly Co Eli Production of plasminogen activator
US3904480A (en) * 1972-10-24 1975-09-09 Lilly Co Eli Enhanced production of plasminogen activator
US4347243A (en) * 1979-10-04 1982-08-31 Research Corporation Acid soluble, pepsin resistant platelet aggregating material
DE3038163A1 (de) * 1980-10-09 1982-05-06 Boehringer Mannheim Gmbh, 6800 Mannheim Thrombininhibitor, seine herstellung und verwendung
AU1516483A (en) * 1982-04-28 1983-11-21 Gray Charles Richardson White Blood products and processes for their production
US4757134A (en) * 1982-12-02 1988-07-12 The Rockefeller University IgA binding protein
DE3315000A1 (de) * 1983-04-26 1984-10-31 Behringwerke Ag, 3550 Marburg Gewebeprotein pp(pfeil abwaerts)4(pfeil abwaerts), verfahren zu seiner gewinnung sowie seine verwendung
JPS60199819A (ja) * 1984-03-23 1985-10-09 Kowa Co トロンビン結合性物質およびその製法
DE3418888A1 (de) * 1984-05-21 1985-11-21 Behringwerke Ag, 3550 Marburg Gewebeprotein pp(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)8(pfeil abwaerts), verfahren zu seiner gewinnung sowie seine verwendung
JPH0689014B2 (ja) * 1986-01-21 1994-11-09 興和株式会社 トロンビン結合性物質およびその製法
DE3710430A1 (de) * 1987-03-28 1989-01-19 Boehringer Ingelheim Int Vascular-antikoagulierende proteine, dna die diese kodieren, verfahren zu deren herstellung sowie deren verwendung
DE3737239A1 (de) * 1987-11-03 1989-10-12 Behringwerke Ag Gentechnische herstellung von anticoagulatorischem protein pp4

Also Published As

Publication number Publication date
FI853611L (fi) 1986-03-22
PT81168A (de) 1985-10-01
ES8702431A1 (es) 1986-12-16
NZ213563A (en) 1991-08-27
HU199883B (en) 1990-03-28
NO164991B (no) 1990-08-27
KR860002567A (ko) 1986-04-26
IE58862B1 (en) 1993-11-17
DE3572179D1 (en) 1989-09-14
HUT39466A (en) 1986-09-29
IE852323L (en) 1986-03-21
IL76441A (en) 1990-07-26
US4736018A (en) 1988-04-05
FI83882B (fi) 1991-05-31
AU596951B2 (en) 1990-05-24
PH23942A (en) 1990-01-23
PT81168B (pt) 1988-01-22
DK427485A (da) 1986-03-22
EP0181465B2 (de) 1994-11-23
ES547139A0 (es) 1986-12-16
DK166587B1 (da) 1993-06-14
FI83882C (fi) 1991-09-10
KR930007434B1 (ko) 1993-08-10
DE3533516A1 (de) 1986-04-03
DK427485D0 (da) 1985-09-20
JPS61137822A (ja) 1986-06-25
AU4768285A (en) 1986-03-27
FI853611A0 (fi) 1985-09-20
EP0181465B1 (de) 1989-08-09
EP0181465A1 (de) 1986-05-21
US5066787A (en) 1991-11-19
IL76441A0 (en) 1986-01-31
JPH0780912B2 (ja) 1995-08-30
CA1244763A (en) 1988-11-15
NO164991C (no) 1990-12-05

Similar Documents

Publication Publication Date Title
NO853700L (no) Blodkoaguleringshemmende proteiner og fremgangsm¨te for fr emstilling derav.
NO872729D0 (no) Cefalosporinhydrat og fremgangsmaate for dets fremstilling.
NO882356L (no) Naeringsmiddel og fremgangsmaate for dets fremstilling.
NO860190L (no) Peptid-derivater og fremgangsmaate for fremstilling derav.
NO884795D0 (no) Rekombinant, humant immunoglobulin og fremgangsmaate for fremstilling av dette.
DK31088A (da) Blodkoaguleringsnedsaettende peptidderivater
DK560784D0 (da) Hoejrenset protein, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende det
NO880434L (no) Bedoevelsesmiddel og fremgangsmaate for bruk derav.
NO884733D0 (no) Roermuffe og fremgangsmaate til fremstilling av samme.
NO882766D0 (no) Katalysatorer og fremgangsmaate for deres fremstilling.
NO862975L (no) Kvaternaere oksalkylerte polykondensater, fremgangsmaate til deres fremstilling, og deres anvendelse.
DK435588A (da) Aralkylaminoalkoxyphenylderivater, fremgangsmaade til deres fremstilling og midler indeholdende disse
DK165952C (da) 1,3-oxazolidin-2-on-derivater og fremgangsmaade til fremstilling heraf
NO901745D0 (no) Fremgangsmaate og system for aa gjennomfoere minesveiping.
DK225788D0 (da) Poroes harpiksfilm og fremmgangsmaade til fremstilling deraf
NO883114D0 (no) 1h-pyrazol-1-alkanamider og fremgangsmaate for deres fremstilling.
NO884324D0 (no) Fremgangsmaate til fremstilling av reninhemmende peptider og deres anvendelse.
NO870210D0 (no) Fremgangsmaate og anordning for avskinning.
NO881713D0 (no) Fremgangsmaate for fremstilling av di-t-butylfenyl-alkyl og benzylethere.
NO863469D0 (no) Herbicid og fremgangsmaate for anvendelse derav.
DK25388D0 (da) Kondenserede pyrazolderivater og fremgangsmaade til fremstilling heraf
DK319188A (da) Glycerolacetalaminoacylat og fremgangsmaade til fremstilling deraf
NO872151D0 (no) Krystallinske, aminobeskyttede aminosyrer og fremgangsmaate for deres fremstilling.
NO864258D0 (no) Skjema for patentprosedyrer og fremgangsmaate for fremstilling av dette.
NO875277D0 (no) Askorbat-2-polyfosfatforbindelser og fremgangsmaate til fremstilling derav.

Legal Events

Date Code Title Description
MK1K Patent expired